Lifestyle factors, body mass index, and lipid profile in adolescents.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 2734117)

Published in J Pediatr Psychol on November 17, 2007

Authors

Marilyn L Cugnetto1, Patrice G Saab, Maria M Llabre, Ronald Goldberg, Judith R McCalla, Neil Schneiderman

Author Affiliations

1: Department of Psychology, University of Miami, PO Box 248185, Coral Gables, Florida, FL 33124-0751, USA. marilyn.cugnetto@gmail.com

Articles cited by this

Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med (2002) 101.79

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation (2002) 76.93

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med (2001) 56.11

Banting lecture 1988. Role of insulin resistance in human disease. Diabetes (1988) 33.22

Mediation in experimental and nonexperimental studies: new procedures and recommendations. Psychol Methods (2002) 19.79

A self-report measure of pubertal status: Reliability, validity, and initial norms. J Youth Adolesc (1988) 12.12

Obesity and insulin resistance. J Clin Invest (2000) 10.47

Physical activity assessment methodology in the Five-City Project. Am J Epidemiol (1985) 7.90

Intensive lifestyle changes for reversal of coronary heart disease. JAMA (1998) 6.53

Outcomes of a field trial to improve children's dietary patterns and physical activity. The Child and Adolescent Trial for Cardiovascular Health. CATCH collaborative group. JAMA (1996) 6.16

Are American children and youth fit? Res Q Exerc Sport (1992) 4.75

Seven-day recall and other physical activity self-reports in children and adolescents. Med Sci Sports Exerc (1993) 3.57

Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning. Lancet (2003) 3.31

Effects on blood lipids of a blood pressure-lowering diet: the Dietary Approaches to Stop Hypertension (DASH) Trial. Am J Clin Nutr (2001) 3.12

A review of validations of dietary assessment methods. Am J Epidemiol (1982) 2.92

Relation of circumferences and skinfold thicknesses to lipid and insulin concentrations in children and adolescents: the Bogalusa Heart Study. Am J Clin Nutr (1999) 2.91

Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta-cell function. Diabetes Care (2004) 2.60

Physical activity, TV viewing, and weight in U.S. youth: 1999 Youth Risk Behavior Survey. Obes Res (2002) 2.21

Promotion of physical activity among high-school girls: a randomized controlled trial. Am J Public Health (2005) 2.04

Body mass index, waist circumference, and clustering of cardiovascular disease risk factors in a biracial sample of children and adolescents. Pediatrics (2004) 2.01

Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes (1997) 1.88

Association of body fat distribution and cardiovascular risk factors in children and adolescents. Circulation (1999) 1.87

Intra-abdominal adipose tissue in young children. Int J Obes Relat Metab Disord (1995) 1.85

Assessing diets of children and adolescents. Am J Clin Nutr (1997) 1.72

The assessment of the body fat percentage by skinfold thickness measurements in childhood and young adolescence. Br J Nutr (1990) 1.58

Metabolic precursors and effects of obesity in children: a decade of progress, 1990-1999. Am J Clin Nutr (2001) 1.49

Childhood obesity and insulin-resistant syndrome. J Pediatr Nurs (2004) 1.44

Unique effect of visceral fat on insulin sensitivity in obese Hispanic children with a family history of type 2 diabetes. Diabetes Care (2002) 1.42

Overview of the determinants of overweight and obesity: current evidence and research issues. Med Sci Sports Exerc (1999) 1.33

Secular trends in variables associated with the metabolic syndrome of North American children and adolescents: a review and synthesis. Am J Hum Biol (2003) 1.31

Fitness, fatness, and coronary heart disease risk in adolescents: the Northern Ireland Young Hearts Project. Med Sci Sports Exerc (2001) 1.20

Dynamic changes of serum lipoproteins in children during adolescence and sexual maturation. Am J Epidemiol (1981) 1.19

Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: medical office assessment: Writing Group I. Circulation (2000) 1.13

Physical activity, physical fitness, and coronary heart disease risk factors in youth: the Québec Family Study. Prev Med (1999) 1.12

Risk stratification of obesity as a coronary risk factor. Am J Cardiol (2002) 1.09

Random repeat 24-hour dietary recalls. Am J Clin Nutr (1971) 1.04

Body fat distribution in pubertal girls quantified by magnetic resonance imaging. Int J Obes Relat Metab Disord (1992) 1.03

Effects of diet and sexual maturation on low-density lipoprotein cholesterol during puberty: the Dietary Intervention Study in Children (DISC). Circulation (1997) 0.94

Which measure of body fat distribution is best for epidemiologic research among adolescents? Am J Epidemiol (1991) 0.84

Efficacy and safety of lowering dietary intake of total fat, saturated fat, and cholesterol in children with elevated LDL cholesterol: the Dietary Intervention Study in Children. Am J Clin Nutr (2000) 0.83

Effects of a curriculum and inservice program on the quantity and quality of elementary physical education classes. Res Q Exerc Sport (1993) 0.82

Secular trends in body dimensions and physical fitness among adolescents in Sweden from 1974 to 1995. Scand J Med Sci Sports (2003) 0.80

Relations of life-style with lipids, blood pressure and insulin in adolescents and young adults. The Cardiovascular Risk in Young Finns Study. Atherosclerosis (1994) 0.80

Selected predictor variables and the lipid-lipoprotein profile of prepubertal girls and boys. Med Sci Sports Exerc (1999) 0.78

How the CATCH eat smart program helps implement the USDA regulations in school cafeterias. Health Educ Behav (2003) 0.77

Blood lipids of young distance runners: distribution and inter-relationships among training volume, peak oxygen consumption, and body fatness. Eur J Appl Physiol (2001) 0.77

Dietary fibre, exercise and serum lipids and lipoprotein cholesterols in 12 to 15 year olds. Acta Paediatr (1998) 0.76

Articles by these authors

10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet (2009) 15.00

Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA (2003) 10.59

European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2007) 6.10

The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. Ann Intern Med (2005) 5.76

Prevalence of major cardiovascular risk factors and cardiovascular diseases among Hispanic/Latino individuals of diverse backgrounds in the United States. JAMA (2012) 5.41

The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology. J Am Coll Cardiol (2005) 5.33

Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program. Diabetes Care (2005) 5.10

Design and implementation of the Hispanic Community Health Study/Study of Latinos. Ann Epidemiol (2010) 4.61

Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics (2006) 3.78

Suppression of human immunodeficiency virus type 1 viral load with selenium supplementation: a randomized controlled trial. Arch Intern Med (2007) 3.58

Very low birth weight preterm infants with early onset neonatal sepsis: the predominance of gram-negative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network, 2002-2003. Pediatr Infect Dis J (2005) 2.85

Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment. Psychosom Med (2005) 2.83

European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2007) 2.70

Cardiovascular reactivity and development of preclinical and clinical disease states. Psychosom Med (2003) 2.69

Social support and prognosis in patients at increased psychosocial risk recovering from myocardial infarction. Health Psychol (2007) 2.57

Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance. Diabetes (2005) 2.46

Cardiometabolic risk in adolescents: associations with physical activity, fitness, and sleep. Ann Behav Med (2013) 2.07

Social support, positive states of mind, and HIV treatment adherence in men and women living with HIV/AIDS. Health Psychol (2004) 1.97

Randomized clinical trial of cognitive behavioral stress management on human immunodeficiency virus viral load in gay men treated with highly active antiretroviral therapy. Psychosom Med (2006) 1.88

Prevalence of hypertension, awareness, treatment, and control in the Hispanic Community Health Study/Study of Latinos. Am J Hypertens (2014) 1.83

Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program. Diabetes (2008) 1.78

Psychosocial considerations in the European guidelines for prevention of cardiovascular diseases in clinical practice: Third Joint Task Force. Int J Behav Med (2005) 1.74

Cyclodextrin protects podocytes in diabetic kidney disease. Diabetes (2013) 1.71

Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study. Psychosom Med (2004) 1.64

Biomarkers of vascular dysfunction in children infected with human immunodeficiency virus-1. J Acquir Immune Defic Syndr (2010) 1.62

Physical symptoms, beliefs about medications, negative mood, and long-term HIV medication adherence. Ann Behav Med (2007) 1.55

A stress and coping model of medication adherence and viral load in HIV-positive men and women on highly active antiretroviral therapy (HAART). Health Psychol (2005) 1.55

A randomized clinical trial of group-based cognitive-behavioral stress management in localized prostate cancer: development of stress management skills improves quality of life and benefit finding. Ann Behav Med (2006) 1.46

Leptin and its association with somatic depressive symptoms in patients with the metabolic syndrome. Ann Behav Med (2013) 1.41

The effect of therapeutic horseback riding on social functioning in children with autism. J Autism Dev Disord (2009) 1.41

Elevated temperature after hypoxic-ischemic encephalopathy: risk factor for adverse outcomes. Pediatrics (2008) 1.39

A measurement model of medication adherence to highly active antiretroviral therapy and its relation to viral load in HIV-positive adults. AIDS Patient Care STDS (2006) 1.38

Is the factor structure of the metabolic syndrome comparable between men and women and across three ethnic groups: the Miami Community Health Study. Ann Epidemiol (2005) 1.35

Evaluation of enzyme immunoassay and radioimmunoassay methods for the measurement of plasma oxytocin. Psychosom Med (2011) 1.35

Reductions in depressed mood and denial coping during cognitive behavioral stress management with HIV-Positive gay men treated with HAART. Ann Behav Med (2006) 1.29

Stress management intervention reduces serum cortisol and increases relaxation during treatment for nonmetastatic breast cancer. Psychosom Med (2008) 1.27

To take or not to take: decision-making about antiretroviral treatment in people living with HIV/AIDS. AIDS Patient Care STDS (2006) 1.24

Stress reduction prolongs life in women with coronary disease: the Stockholm Women's Intervention Trial for Coronary Heart Disease (SWITCHD). Circ Cardiovasc Qual Outcomes (2009) 1.24

Predictive value of an early amplitude integrated electroencephalogram and neurologic examination. Pediatrics (2011) 1.21

Oxytocin attenuates NADPH-dependent superoxide activity and IL-6 secretion in macrophages and vascular cells. Am J Physiol Endocrinol Metab (2008) 1.21

Resolved: psychosocial interventions can improve clinical outcomes in organic disease (pro). Psychosom Med (2002) 1.19

Dispositional optimism and the mechanisms by which it predicts slower disease progression in HIV: proactive behavior, avoidant coping, and depression. Int J Behav Med (2005) 1.18

Cognitive-behavioral interventions improve quality of life in women with AIDS. J Psychosom Res (2003) 1.17

C-reactive protein is elevated in obese patients with the metabolic syndrome. Diabetes Res Clin Pract (2005) 1.17

Prevalence and risk factors associated with the metabolic syndrome and dyslipidemia in White, Black, Amerindian and Mixed Hispanics in Zulia State, Venezuela. Diabetes Res Clin Pract (2005) 1.15

Decreased depression up to one year following CBSM+ intervention in depressed women with AIDS: the smart/EST women's project. J Health Psychol (2005) 1.15

A path model of the effects of spirituality on depressive symptoms and 24-h urinary-free cortisol in HIV-positive persons. J Psychosom Res (2006) 1.14

MACH14: a multi-site collaboration on ART adherence among 14 institutions. AIDS Behav (2013) 1.14

Cognitive-behavioral stress management improves stress-management skills and quality of life in men recovering from treatment of prostate carcinoma. Cancer (2004) 1.13

Stress management and immune system reconstitution in symptomatic HIV-infected gay men over time: effects on transitional naive T cells (CD4(+)CD45RA(+)CD29(+)). Am J Psychiatry (2002) 1.13

View of God as benevolent and forgiving or punishing and judgmental predicts HIV disease progression. J Behav Med (2011) 1.12

Behavioural medicine: changing our behaviour. BMJ (2006) 1.11

Predictors of treatment response for depression and inadequate social support--the ENRICHD randomized clinical trial. Psychother Psychosom (2007) 1.10

Increases in a marker of immune system reconstitution are predated by decreases in 24-h urinary cortisol output and depressed mood during a 10-week stress management intervention in symptomatic HIV-infected men. J Psychosom Res (2005) 1.10

Exercise, depression, and mortality after myocardial infarction in the ENRICHD trial. Med Sci Sports Exerc (2004) 1.10

Psychosocial treatment within sex by ethnicity subgroups in the Enhancing Recovery in Coronary Heart Disease clinical trial. Psychosom Med (2004) 1.10

The rebirth of neuroscience in psychosomatic medicine, Part II: clinical applications and implications for research. Psychosom Med (2009) 1.10

Psychosocial risk factors for cardiovascular disease: more than one culprit at work. JAMA (2003) 1.09

Cognitive and somatic symptoms of depression are associated with medical comorbidity in patients after acute myocardial infarction. Am Heart J (2003) 1.09

Personality, quality of life and HAART adherence among men and women living with HIV/AIDS. J Psychosom Res (2003) 1.08

Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group IV: lifestyle and medical management of risk factors. Circulation (2002) 1.07

"It's my body'': does patient involvement in decision making reduce decisional conflict? Med Decis Making (2007) 1.07

Weight management for veterans: examining change in weight before and after MOVE! Obesity (Silver Spring) (2010) 1.07

Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13. J Med Chem (2009) 1.06

Resolved: psychosocial interventions can improve clinical outcomes in organic disease--rebuttals and closing arguments. Psychosom Med (2002) 1.05

Psychosocial and behavioral interventions for chronic medical conditions. Curr Opin Psychiatry (2007) 1.04

Cognitive behavioral stress management intervention improves quality of life in Spanish monolingual hispanic men treated for localized prostate cancer: results of a randomized controlled trial. Int J Behav Med (2007) 1.04

Enhancing the health of women living with HIV: the SMART/EST Women's Project. Int J Womens Health (2011) 1.04

The rebirth of neuroscience in psychosomatic medicine, Part I: historical context, methods, and relevant basic science. Psychosom Med (2009) 1.03

Perceived stress mediates the effects of coping on the quality of life of HIV-positive women on highly active antiretroviral therapy. AIDS Behav (2004) 1.03

Improving dietary habits in disadvantaged women with HIV/AIDS: the SMART/EST women's project. AIDS Behav (2006) 1.03

Ethnicity and determinants of quality of life after prostate cancer treatment. Urology (2006) 1.03

Adiponectin and carotid intima-media thickness in the northern Manhattan study. Stroke (2011) 1.02

The effect of social environment on markers of vascular oxidative stress and inflammation in the Watanabe heritable hyperlipidemic rabbit. Psychosom Med (2008) 1.01

Emotional expression and depth processing of trauma and their relation to long-term survival in patients with HIV/AIDS. J Psychosom Res (2003) 1.01

Increased apolipoprotein C-III levels associated with insulin resistance contribute to dyslipidemia in normoglycemic and diabetic subjects from a triethnic population. Atherosclerosis (2005) 1.00

Cognitive behavioral stress management effects on injury and illness among competitive athletes: a randomized clinical trial. Ann Behav Med (2003) 1.00

Illness perceptions and emotional well-being in men treated for localized prostate cancer. J Psychosom Res (2009) 1.00

Men's serostatus disclosure to parents: associations among social support, ethnicity, and disease status in men living with HIV. Brain Behav Immun (2009) 1.00

Personality and HIV disease progression: role of NEO-PI-R openness, extraversion, and profiles of engagement. Psychosom Med (2008) 0.99

Social Support Mediates Loneliness and Human Herpesvirus Type 6 (HHV-6) Antibody Titers. J Appl Soc Psychol (2006) 0.99

Sexual functioning and quality of life after prostate cancer treatment: considering sexual desire. Urology (2004) 0.99

Emotional support and gender in people living with HIV: effects on psychological well-being. J Behav Med (2009) 0.96

Social environment influences the progression of atherosclerosis in the watanabe heritable hyperlipidemic rabbit. Circulation (2002) 0.95

Cognitive-behavioural stress management with HIV-positive homosexual men: mechanisms of sustained reductions in depressive symptoms. Chronic Illn (2005) 0.95

The validity of self-reported medication adherence as an outcome in clinical trials of adherence-promotion interventions: Findings from the MACH14 study. AIDS Behav (2014) 0.95

Longitudinal effects of social support and adaptive coping on the emotional well-being of survivors of localized prostate cancer. J Support Oncol (2010) 0.94

Ethnicity, gender, and age effects on adrenoceptors and physiological responses to emotional stress. Psychophysiology (2004) 0.94

Coping and psychological distress among symptomatic HIV+ men who have sex with men. Ann Behav Med (2003) 0.92

Oxytocin attenuates atherosclerosis and adipose tissue inflammation in socially isolated ApoE-/- mice. Psychosom Med (2010) 0.92